Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in HFrEF.

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Professor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

8 More presentations in this session

Presentation thumbnail

Association between heart failure medication at discharge and heart failure readmission

Doctor G. Linssen (Almelo, NL)

Abstract Slides

Presentation thumbnail

Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis involving 48,628 patients

Doctor C. Kapelios (Athens, GR)

Abstract Slides

Presentation thumbnail

Combined effects of growth hormone and testosterone replacement treatment in heart failure

Doctor A. Salzano (Naples, IT)

Presentation thumbnail

FE- IRON (First Ever Irish heart failure nurses group Review On implementation of ESC iroN guideline in Ireland)

Ms M. Carey (Dublin, IE)

Abstract Slides

Presentation thumbnail

Effect of ferric carboxymaltose on LVEF as assessed by cardiac MRI in patients with chronic heart failure and iron deficiency: a randomized, double-blinded, placebo-controlled, dual-center trial

Doctor M. Karakas (Hamburg, DE)

Access the full session

Session thumbnail

Moderated Poster Session - Chronic heart failure

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources